CASZ1 and cancer: We noticed that overexpressed CASZ1 was involved in cancer‐related signaling pathways and multiple immune‐inflammatory signaling pathways, including “B‐cell receptor signaling pathway,” “Toll‐like receptor signaling pathway,” “T‐cell receptor signaling pathway,” and “NF‐Kappa B signaling pathway” (Figure S1).